Datu, Baby Boy D.

HRN: 28-88-53  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2026
CEFTAZIDIME 1GM (VIAL)
04/23/2026
04/30/2026
IV
102mg
Q12H
Neonatal Pneumonia VS Neontal Sepsis
Checking Initial Appropriateness 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines